89bio, Inc.

This study tested whether a new drug called BIO89-100 could help people with a serious fatty liver disease called NASH. 222 adults with confirmed liver scarring received either the drug or a placebo injection weekly for 24 weeks. Researchers checked if the treatment could reduce …